Comparing Two Steroid Doses Injected Into the Knee for Arthritis in Obese Adults
Tests a low steroid dose against a standard dose injected into the knee for arthritis.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Jacksonville, United StatesSee the site
- Trial code
- Registry title
- Knee Injections for Obese Patients With Knee Arthritis
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 40 people, planned
- Started
- 24 Jan 2025
- Expected to end
- 24 Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Triamcinolone Acetonide Low Dose
- Triamcinolone Acetonide Standard Dose
- Record updated
- 10 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 55 to 85 with obesity and knee osteoarthritis confirmed on X-ray who want a steroid knee injection. It compares a low dose with a standard dose.
- Age
- 55 to 85 years
- Sex
- All sexes can join.
- Disease stage
- Knee osteoarthritis (knee arthritis) proven on X-ray, with BMI of 30 kg/m2 or higher.
- Earlier treatment
- People cannot have other treatment during the study or be in physical therapy at the time of the study.
Main reasons for not taking part
- BMI below 30 kg/m2
- Uncontrolled diabetes with a hemoglobin A1c above 8% (64 mmol/mol)
- Any other treatment during the study
- Physical therapy at the time of the study
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients with BMI ≥30 kg/m2 and radiograph-proven knee osteoarthritis who are interested in receiving a steroid injection for knee arthritis
Who cannot take part
- Patients that are undergoing physical therapy at the time of the study
- Uncontrolled diabetics with a hemoglobin A1c > 8%
- BMI < 30 kg/m2
- No other treatment within the time frame of the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 55 and 85 years old?
Where in United States
- Mayo Clinic in FloridaJacksonville, United StatesContact: Jeffrey P Nadwodny, DOTaking people
About the trial
What the trial wants to find out
The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.
The 2 groups in the trial
- Standard Dose GroupExisting treatment, for comparison
Patients with knee osteoarthritis who are interested in knee intra-articular corticosteroid injections and meet the inclusion criteria.
Treatment: Triamcinolone Acetonide Standard Dose
- Lower Dose GroupTreatment being tested
Patients with knee osteoarthritis who are interested in knee intra-articular corticosteroid injections and meet the inclusion criteria.
Treatment: Triamcinolone Acetonide Low Dose
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Comparison of Varying Doses of Steroid for Intra-articular Knee Injections
- Plain-language title
- Comparing Two Steroid Doses Injected Into the Knee for Arthritis in Obese AdultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06782529, who can take part
- Record updated
- 10 March 2026